NASDAQ:CERE

Delisted

Cerevel Therapeutics Holdings Stock News

Healthcare > Biotechnology

Buy CERE

*Your capital is at risk

$44.96

+0 (+0%)

At Close: Oct 30, 2024

CERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

11:58am, Wednesday, 07'th May 2025

LOS ANGELES , May 7, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cerevel Therapeutics Holdings, Inc.

Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm

10:42am, Wednesday, 07'th May 2025

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics

10:30am, Wednesday, 07'th May 2025

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Cerevel To Contact Him Directly To Discuss Their Options A class action w

CERE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

07:00am, Wednesday, 07'th May 2025

NEW YORK CITY, NY / ACCESS Newswire / May 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cerevel

CERE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Cerevel Therapeutics Holdings, Inc. to Contact the Firm Today!

07:00am, Tuesday, 06'th May 2025

NEW YORK CITY, NY / ACCESS Newswire / May 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cerevel

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

03:39pm, Monday, 05'th May 2025

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock

ROSEN, LEADING INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

12:45pm, Monday, 05'th May 2025

NEW YORK CITY, NY / ACCESS Newswire / May 5, 2025 / WHY: New York, N.Y., May 5, 2025.

CERE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Cerevel Therapeutics Holdings, Inc. to Contact the Firm Today!

07:00am, Monday, 05'th May 2025

NEW YORK CITY, NY / ACCESS Newswire / May 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cerevel

ROSEN, LEADING INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

12:00pm, Sunday, 04'th May 2025

NEW YORK CITY, NY / ACCESS Newswire / May 4, 2025 / WHY: New York, N.Y., May 4, 2025.

CERE Stockholders Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

07:00am, Sunday, 04'th May 2025

NEW YORK CITY, NY / ACCESS Newswire / May 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cerevel

ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

08:00pm, Saturday, 03'rd May 2025

NEW YORK CITY, NY / ACCESS Newswire / May 3, 2025 / WHY: New York, N.Y., May 3, 2025.

CERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud Lawsuit

01:00pm, Saturday, 03'rd May 2025

NEW YORK , May 3, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds all persons or entities that: (1) sold or otherwise disposed of the publicly-traded common stock of C

CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

04:00pm, Friday, 02'nd May 2025

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed ag

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE

01:25pm, Friday, 02'nd May 2025

NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / WHY: New York, N.Y., May 2, 2025.

Faruqi & Faruqi Reminds Cerevel Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - CERE

11:28am, Friday, 02'nd May 2025

NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Cerevel To Contact Hi

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by